Question 1

What is Arcadia Biosciences, Inc.'s WACC?

Accepted Answer

Arcadia Biosciences, Inc. (RKDA) has a Weighted Average Cost of Capital (WACC) of 7.40%. This is calculated using a Cost of Equity of 7.40% (via CAPM with a beta of 0.60) and a pre-tax Cost of Debt of 5.00%, with an equity weight of 100.00% in the capital structure.

Question 2

Is Arcadia Biosciences, Inc.'s WACC high or low?

Accepted Answer

Arcadia Biosciences, Inc.'s WACC of 7.40% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Arcadia Biosciences, Inc.'s WACC calculated?

Accepted Answer

Arcadia Biosciences, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.40% is derived from the CAPM model using a beta of 0.60. The pre-tax Cost of Debt (Rd) is 5.00%. The capital structure is 100.00% equity and 0.00% debt.

Arcadia Biosciences, Inc. (RKDA) — WACC 分析

WACC 构成

解读

Arcadia Biosciences, Inc.（RKDA）WACC：7.40%

WACC计算器

Arcadia Biosciences, Inc.（RKDA） WACC 解读

RKDA 公司分析

RKDA DCF 估值

继续做同行对比